Daniel Ciccarone on Muck Rack

Daniel Ciccarone

San Francisco
As seen in: National Institutes of Health, American Journal of Public Health Podcast, Color Research & Application, Wiley Online Library, Harm Reduction Journal, PLOS ONE, MDPI, The Hill, JAMA (The Journal of the American Medical Association), American Journal of Public Health
Professor of Family & Community Medicine at UCSF. Public health researcher at intersection of HIV and drug use. P.I. of Heroin in Transition Study (NIH/NIDA).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Daniel

Contact Daniel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Charting the decline of the fourth wave: US overdose deaths by race, ethnicity and substance involvement

|
By Joseph Friedman, Joseph Palamar, Daniel Ciccarone
| Wiley Online Library Verified
INTRODUCTION After many years of rapid increases, overdose death rates in the USA have begun decreasing, drawing considerable public attention [1-3]. The US overdose crisis has been characterized by a ‘four-wave’ paradigm, wherein an escalating death rate was attributed to shifting drug profiles over time [4-6]. The first wave entailed a surge in deaths involving commonly prescribed opioids [7]. Subsequently, in wave 2, drug overdose deaths involving heroin increased rapidly [8].
Open in Who Shared Issue with article?

The 2025 Drug Overdose Spike That Wasn’t: Neither Politics nor Data Errors Explain the Anomaly

|
By Daniel Ciccarone, Alexander Lundberg, Maryann Mason
| American Journal of Public Health Podcast
Starting in August 2023, drug overdose deaths (DODs) entered the longest decline in more than 40 years.1,2 The “great deceleration” brought cautious optimism to public health leaders and academics alike.
Open in Who Shared Issue with article?

“Everyone says ‘safe sex’ but no one ever says ‘safe drugs’, you know?”: Perspectives on the intersection of drug checking services, drug policy and the overdose crisis

|
By Jeff Ondocsin, Lissa Moran, Daniel Ciccarone
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Ondocsin J, Moran L, Ciccarone D, Outram S, Werb D, Holm N, et al. (2025) “Everyone says ‘safe sex’ but no one ever says ‘safe drugs’, you know?”: Perspectives on the intersection of drug checking services, drug policy and the overdose crisis. PLoS ONE 20(4): e0321574.
Open in Who Shared Issue with article?
See all 21 licensed articles (22 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified